Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.73 -0.37 (-0.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Current Assets (2017 - 2026)

Updated

Kiniksa Pharmaceuticals International (KNSA) reported Current Assets of $668.63 million for Q2 2026, up 59.1% from $420.31 million a year earlier and up 12.5% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Current Assets (2017 - 2026) Analysis & Trends

At the end of FY2025, Kiniksa Pharmaceuticals International posted Current Assets of $527.18 million, up 58.9% from FY2024.

  • Current Assets has increased for four consecutive years, with a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
  • By year, Current Assets came in at $331.8 million in FY2024 (+20.1%), $276.3 million in FY2023 (+13.7%), $243.06 million in FY2022 (+23.7%) and $196.45 million in FY2021 (-41.1%).
  • The Q2 2026 figure ranks as the highest quarterly Current Assets in data going back to Q4 2017.
  • Year over year, Current Assets has now increased in each of the last 16 quarters, with growth averaging 43.8% over the last eight quarters.
  • The high point for year-over-year Current Assets in five years was Q1 2026 (growth of 66.9%); the low point was Q3 2021 (a decline of 42.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $594.17 million (Q1 2026), $527.18 million (Q4 2025) and $475.53 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Kiniksa Pharmaceuticals International 11.87 Bn 10.61 Bn 220.03 Mn 668.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 668.63 Mn
Mar 31, 2026 594.17 Mn
Dec 31, 2025 527.18 Mn
Sep 30, 2025 475.53 Mn
Jun 30, 2025 420.31 Mn
Mar 31, 2025 355.91 Mn
Dec 31, 2024 331.80 Mn
Sep 30, 2024 311.30 Mn
Jun 30, 2024 301.02 Mn
Mar 31, 2024 270.59 Mn
Dec 31, 2023 276.30 Mn
Sep 30, 2023 256.11 Mn
Jun 30, 2023 246.04 Mn
Mar 31, 2023 231.50 Mn
Dec 31, 2022 243.06 Mn
Sep 30, 2022 241.82 Mn
Jun 30, 2022 179.94 Mn
Mar 31, 2022 198.76 Mn
Dec 31, 2021 196.45 Mn
Sep 30, 2021 217.51 Mn
API Access

Kiniksa Pharmaceuticals International Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=KNSA&period=max&api_key=YOUR_API_KEY